Cargando…
Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257485/ https://www.ncbi.nlm.nih.gov/pubmed/33328591 http://dx.doi.org/10.1038/s41375-020-01108-x |
| _version_ | 1783718324530577408 |
|---|---|
| author | Morschhauser, Franck Dyer, Martin J. S. Walter, Harriet S. Danilov, Alexey V. Ysebaert, Loic Hodson, Daniel James Fegan, Christopher Rule, Simon A. Radford, John Cartron, Guillaume Bouabdallah, Krimo Davies, Andrew John Spurgeon, Stephen Rajakumaraswamy, Nishanthan Li, Biao Humeniuk, Rita Huang, Xi Bhargava, Pankaj Jürgensmeier, Juliane M. Salles, Gilles |
| author_facet | Morschhauser, Franck Dyer, Martin J. S. Walter, Harriet S. Danilov, Alexey V. Ysebaert, Loic Hodson, Daniel James Fegan, Christopher Rule, Simon A. Radford, John Cartron, Guillaume Bouabdallah, Krimo Davies, Andrew John Spurgeon, Stephen Rajakumaraswamy, Nishanthan Li, Biao Humeniuk, Rita Huang, Xi Bhargava, Pankaj Jürgensmeier, Juliane M. Salles, Gilles |
| author_sort | Morschhauser, Franck |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8257485 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82574852021-07-23 Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma Morschhauser, Franck Dyer, Martin J. S. Walter, Harriet S. Danilov, Alexey V. Ysebaert, Loic Hodson, Daniel James Fegan, Christopher Rule, Simon A. Radford, John Cartron, Guillaume Bouabdallah, Krimo Davies, Andrew John Spurgeon, Stephen Rajakumaraswamy, Nishanthan Li, Biao Humeniuk, Rita Huang, Xi Bhargava, Pankaj Jürgensmeier, Juliane M. Salles, Gilles Leukemia Letter Nature Publishing Group UK 2020-12-17 2021 /pmc/articles/PMC8257485/ /pubmed/33328591 http://dx.doi.org/10.1038/s41375-020-01108-x Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Morschhauser, Franck Dyer, Martin J. S. Walter, Harriet S. Danilov, Alexey V. Ysebaert, Loic Hodson, Daniel James Fegan, Christopher Rule, Simon A. Radford, John Cartron, Guillaume Bouabdallah, Krimo Davies, Andrew John Spurgeon, Stephen Rajakumaraswamy, Nishanthan Li, Biao Humeniuk, Rita Huang, Xi Bhargava, Pankaj Jürgensmeier, Juliane M. Salles, Gilles Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma |
| title | Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma |
| title_full | Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma |
| title_fullStr | Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma |
| title_full_unstemmed | Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma |
| title_short | Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma |
| title_sort | phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated b-cell lymphoma |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257485/ https://www.ncbi.nlm.nih.gov/pubmed/33328591 http://dx.doi.org/10.1038/s41375-020-01108-x |
| work_keys_str_mv | AT morschhauserfranck phase1bstudyoftirabrutinibincombinationwithidelalisiborentospletinibinpreviouslytreatedbcelllymphoma AT dyermartinjs phase1bstudyoftirabrutinibincombinationwithidelalisiborentospletinibinpreviouslytreatedbcelllymphoma AT walterharriets phase1bstudyoftirabrutinibincombinationwithidelalisiborentospletinibinpreviouslytreatedbcelllymphoma AT danilovalexeyv phase1bstudyoftirabrutinibincombinationwithidelalisiborentospletinibinpreviouslytreatedbcelllymphoma AT ysebaertloic phase1bstudyoftirabrutinibincombinationwithidelalisiborentospletinibinpreviouslytreatedbcelllymphoma AT hodsondanieljames phase1bstudyoftirabrutinibincombinationwithidelalisiborentospletinibinpreviouslytreatedbcelllymphoma AT feganchristopher phase1bstudyoftirabrutinibincombinationwithidelalisiborentospletinibinpreviouslytreatedbcelllymphoma AT rulesimona phase1bstudyoftirabrutinibincombinationwithidelalisiborentospletinibinpreviouslytreatedbcelllymphoma AT radfordjohn phase1bstudyoftirabrutinibincombinationwithidelalisiborentospletinibinpreviouslytreatedbcelllymphoma AT cartronguillaume phase1bstudyoftirabrutinibincombinationwithidelalisiborentospletinibinpreviouslytreatedbcelllymphoma AT bouabdallahkrimo phase1bstudyoftirabrutinibincombinationwithidelalisiborentospletinibinpreviouslytreatedbcelllymphoma AT daviesandrewjohn phase1bstudyoftirabrutinibincombinationwithidelalisiborentospletinibinpreviouslytreatedbcelllymphoma AT spurgeonstephen phase1bstudyoftirabrutinibincombinationwithidelalisiborentospletinibinpreviouslytreatedbcelllymphoma AT rajakumaraswamynishanthan phase1bstudyoftirabrutinibincombinationwithidelalisiborentospletinibinpreviouslytreatedbcelllymphoma AT libiao phase1bstudyoftirabrutinibincombinationwithidelalisiborentospletinibinpreviouslytreatedbcelllymphoma AT humeniukrita phase1bstudyoftirabrutinibincombinationwithidelalisiborentospletinibinpreviouslytreatedbcelllymphoma AT huangxi phase1bstudyoftirabrutinibincombinationwithidelalisiborentospletinibinpreviouslytreatedbcelllymphoma AT bhargavapankaj phase1bstudyoftirabrutinibincombinationwithidelalisiborentospletinibinpreviouslytreatedbcelllymphoma AT jurgensmeierjulianem phase1bstudyoftirabrutinibincombinationwithidelalisiborentospletinibinpreviouslytreatedbcelllymphoma AT sallesgilles phase1bstudyoftirabrutinibincombinationwithidelalisiborentospletinibinpreviouslytreatedbcelllymphoma |